Koers Rock Creek Pharmaceuticals Inc Nasdaq
Aandelen
US7720812046
Farmaceutische producten
Omzet 2014 | - | Omzet 2015 | - | Marktkapitalisatie | 8,21 mln. 7,56 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -38 mln. -34,99 mln. | Nettowinst (verlies) 2015 | -6 mln. -5,52 mln. | EV/omzet 2014 | - |
Nettoliquiditeiten 2014 | 45K 41,43K | Nettoschuld 2015 | 19,86 mln. 18,28 mln. | EV/omzet 2015 | - |
K/w-verhouding 2014 |
-0,87
x | K/w-verhouding 2015 |
-1,04
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 723 mld. | |
+32,82% | 598 mld. | |
-3,51% | 364 mld. | |
+19,94% | 331 mld. | |
+5,14% | 288 mld. | |
+16,64% | 244 mld. | |
-4,13% | 208 mld. | |
+10,63% | 210 mld. | |
+9,32% | 169 mld. |